Plasma exchange for primary autoimmune autonomic failure
Christoph Schroeder1, Steven Vernino, Andreas L Birkenfeld
1Franz Volhard Clinical Research Center and the Max Delbrück Center for Molecular Medicine, Berlin.
Severe autonomic failure impacting sympathetic and parasympathetic nerves improved dramatically after removing antibodies against ganglionic acetylcholine receptors via plasma exchange.
Area of Science:
- Neurology
- Immunology
Background:
- Autonomic failure involves dysfunction of the sympathetic and parasympathetic nervous systems.
- Ganglionic acetylcholine receptors play a crucial role in neurotransmission within the autonomic nervous system.
Observation:
- A patient presented with long-standing, severe autonomic failure affecting both sympathetic and parasympathetic functions.
- Serum analysis revealed the presence of antibodies targeting ganglionic acetylcholine receptors.
Findings:
- The patient's condition showed significant clinical improvement following plasma exchange.
- This suggests a causal link between the detected antibodies and the autonomic dysfunction.
Implications:
- Plasma exchange can be an effective therapeutic strategy for autonomic failure associated with anti-ganglionic acetylcholine receptor antibodies.
- Further research into autoimmune mechanisms underlying autonomic neuropathies is warranted.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:15Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Heart Failure VI: Adjunct Therapies
Continuous Renal Replacement Therapy
